However, all of the three pathogenic variants, KRAS (G12D), GNAS (R201C), and FBXW7 (R367*) remained positive in the recurrent tumor with VAFs ranging from 1.9 to 4.3% (Fig. 4a). The gene discussed is KRAS; the disease is neoplasm.